questionsmedicales.fr
Environnement et santé publique
Santé publique
Hygiène radiologique
Contrôle des radiations
Dosimétrie par luminescence stimulée optiquement
Dosimétrie par luminescence stimulée optiquement : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dosimétrie par luminescence stimulée optiquement : Questions médicales les plus fréquentes",
"headline": "Dosimétrie par luminescence stimulée optiquement : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dosimétrie par luminescence stimulée optiquement : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dosimétrie par luminescence stimulée optiquement"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Contrôle des radiations",
"url": "https://questionsmedicales.fr/mesh/D011834",
"about": {
"@type": "MedicalCondition",
"name": "Contrôle des radiations",
"code": {
"@type": "MedicalCode",
"code": "D011834",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.810.370"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Dosimétrie par luminescence stimulée optiquement",
"alternateName": "Optically Stimulated Luminescence Dosimetry",
"code": {
"@type": "MedicalCode",
"code": "D062791",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Renata Majgier",
"url": "https://questionsmedicales.fr/author/Renata%20Majgier",
"affiliation": {
"@type": "Organization",
"name": "Department of Experimental and Applied Physics, Faculty of Science and Technology, Jan Dlugosz University, ul. Armii Krajowej 13/15, 42-200 Czestochowa, Poland."
}
},
{
"@type": "Person",
"name": "Eduardo G Yukihara",
"url": "https://questionsmedicales.fr/author/Eduardo%20G%20Yukihara",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Safety and Security, Paul Scherrer Institute, 5200 Villigen, Switzerland."
}
},
{
"@type": "Person",
"name": "Rosana M Turtos",
"url": "https://questionsmedicales.fr/author/Rosana%20M%20Turtos",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark."
}
},
{
"@type": "Person",
"name": "Mads L Jensen",
"url": "https://questionsmedicales.fr/author/Mads%20L%20Jensen",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark."
}
},
{
"@type": "Person",
"name": "Ludvig P Muren",
"url": "https://questionsmedicales.fr/author/Ludvig%20P%20Muren",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Medicine, Aarhus University, 8000 Aarhus C, Denmark."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Zambian Parents' Perspectives on Early-Infant Versus Early-Adolescent Male Circumcision.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36692607",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10461-022-03912-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early-onset gout.",
"datePublished": "2024-02-07",
"url": "https://questionsmedicales.fr/article/38336273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbspin.2024.105704"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early Steps in the O",
"datePublished": "2023-11-21",
"url": "https://questionsmedicales.fr/article/37988629",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jpca.3c05383"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early warning for SpO",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37551627",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/pan.14743"
}
},
{
"@type": "ScholarlyArticle",
"name": "An integrated method for detecting lung cancer via CT scanning via optimization, deep learning, and IoT data transmission.",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39435294",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2024.1435041"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hygiène radiologique",
"item": "https://questionsmedicales.fr/mesh/D011870"
},
{
"@type": "ListItem",
"position": 5,
"name": "Contrôle des radiations",
"item": "https://questionsmedicales.fr/mesh/D011834"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dosimétrie par luminescence stimulée optiquement",
"item": "https://questionsmedicales.fr/mesh/D062791"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dosimétrie par luminescence stimulée optiquement - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dosimétrie par luminescence stimulée optiquement",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dosimétrie par luminescence stimulée optiquement",
"description": "Comment fonctionne la dosimétrie OSLD ?\nQuels matériaux sont utilisés en OSLD ?\nQuelle est la précision de l'OSLD ?\nL'OSLD est-elle utilisée en médecine ?\nQuels sont les avantages de l'OSLD ?",
"url": "https://questionsmedicales.fr/mesh/D062791?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dosimétrie par luminescence stimulée optiquement",
"description": "Quels symptômes indiquent une exposition à la radiation ?\nComment détecter une exposition excessive ?\nQuels effets à long terme de l'exposition existent ?\nL'OSLD peut-elle détecter des symptômes ?\nQuels signes de surdosage sont observables ?",
"url": "https://questionsmedicales.fr/mesh/D062791?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dosimétrie par luminescence stimulée optiquement",
"description": "Comment réduire l'exposition aux radiations ?\nQuels équipements de protection sont recommandés ?\nL'OSLD aide-t-elle à la prévention ?\nQuelles formations sont nécessaires pour l'OSLD ?\nComment sensibiliser aux risques radiologiques ?",
"url": "https://questionsmedicales.fr/mesh/D062791?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dosimétrie par luminescence stimulée optiquement",
"description": "Comment l'OSLD aide-t-elle en radiothérapie ?\nQuels traitements nécessitent une dosimétrie précise ?\nL'OSLD est-elle utilisée pour le suivi des patients ?\nQuels protocoles de traitement utilisent l'OSLD ?\nL'OSLD peut-elle être utilisée en recherche ?",
"url": "https://questionsmedicales.fr/mesh/D062791?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dosimétrie par luminescence stimulée optiquement",
"description": "Quelles complications peuvent survenir après exposition ?\nComment l'OSLD aide-t-elle à éviter les complications ?\nQuels sont les effets secondaires de la radiothérapie ?\nL'OSLD peut-elle prévenir les complications ?\nQuels suivis sont nécessaires après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D062791?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dosimétrie par luminescence stimulée optiquement",
"description": "Quels facteurs augmentent le risque d'exposition ?\nLes enfants sont-ils plus à risque ?\nComment l'âge influence-t-il le risque ?\nQuels comportements augmentent le risque ?\nLes antécédents médicaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D062791?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment fonctionne la dosimétrie OSLD ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle mesure la lumière émise par des matériaux après exposition à des radiations."
}
},
{
"@type": "Question",
"name": "Quels matériaux sont utilisés en OSLD ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cristaux comme l'alumine ou le silicate sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est la précision de l'OSLD ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'OSLD offre une précision élevée, souvent dans les 5% pour les doses mesurées."
}
},
{
"@type": "Question",
"name": "L'OSLD est-elle utilisée en médecine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour mesurer les doses de radiation en radiothérapie."
}
},
{
"@type": "Question",
"name": "Quels sont les avantages de l'OSLD ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est sensible, portable et peut être utilisée dans divers environnements."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition à la radiation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, des vomissements et des brûlures cutanées peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment détecter une exposition excessive ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosimètres OSLD peuvent être utilisés pour mesurer l'exposition cumulée."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme de l'exposition existent ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des risques accrus de cancer et de maladies génétiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'OSLD peut-elle détecter des symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'OSLD mesure la dose de radiation, pas les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels signes de surdosage sont observables ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de cheveux et troubles sanguins peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Comment réduire l'exposition aux radiations ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des protections appropriées et limiter le temps d'exposition."
}
},
{
"@type": "Question",
"name": "Quels équipements de protection sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tabliers plombés et des écrans de protection sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "L'OSLD aide-t-elle à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet de surveiller l'exposition et d'ajuster les protocoles."
}
},
{
"@type": "Question",
"name": "Quelles formations sont nécessaires pour l'OSLD ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations en radioprotection et en dosimétrie sont essentielles."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser aux risques radiologiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des formations peuvent être mises en place."
}
},
{
"@type": "Question",
"name": "Comment l'OSLD aide-t-elle en radiothérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de mesurer avec précision la dose administrée au patient."
}
},
{
"@type": "Question",
"name": "Quels traitements nécessitent une dosimétrie précise ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements de cancer et les procédures de radiologie interventionnelle."
}
},
{
"@type": "Question",
"name": "L'OSLD est-elle utilisée pour le suivi des patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour surveiller l'exposition des patients au fil du temps."
}
},
{
"@type": "Question",
"name": "Quels protocoles de traitement utilisent l'OSLD ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles de radiothérapie et de radiologie diagnostique l'intègrent."
}
},
{
"@type": "Question",
"name": "L'OSLD peut-elle être utilisée en recherche ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour des études sur les effets des radiations."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des cancers et des maladies cardiovasculaires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment l'OSLD aide-t-elle à éviter les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de contrôler les doses administrées pour éviter les surdosages."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la radiothérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, nausées et troubles cutanés sont des effets secondaires fréquents."
}
},
{
"@type": "Question",
"name": "L'OSLD peut-elle prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en assurant une administration précise des doses de radiation."
}
},
{
"@type": "Question",
"name": "Quels suivis sont nécessaires après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers pour détecter d'éventuelles complications sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Travail dans des environnements radiologiques ou médicalement exposés."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus sensibles aux effets des radiations."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir une sensibilité accrue aux radiations."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme et l'exposition à des produits chimiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer ou de radiothérapie augmentent le risque."
}
}
]
}
]
}
Despite increasing interest in Early-Infant and Early-Adolescent Medical Circumcision (EIMC and EAMC, respectively) in Zambia, parental willingness to have their sons undergo the procedure has not bee...
Early-onset gout (EOG) is characterized by the occurrence of the first symptoms of gout at an unusually young age, usually <40 years. The aim of this review is to provide an overview of the epidemiolo...
We investigate the first direct proton abstraction reactions from reducing agents (...
Continuously assessing the oxygenation levels of patients to detect and prevent hypoxemia can be advantageous for safe anesthesia, especially in neonates and small infants. The oxygen reserve index (O...
ORI and SpO...
The ORI of 100 small infants and neonates with a median age of 9 months (min-max, 0-21 months) and weight of 8.35 kg (min-max, 2-13 kg) were measured. For the ORI/PaO...
The ORI provided an early warning time for detecting an impending SpO...
With its increasing global prevalence, lung cancer remains a critical health concern. Despite the advancement of screening programs, patient selection and risk stratification pose significant challeng...
The primary goal of this study is to evaluate the capabilities of Large Language Models (LLMs) in understanding and processing complex medical documentation. We chose to focus on the identification of...
The study utilized two analytical pipelines, developed with open-source LLMs within the healthcare system's computing environment. First, we extracted embeddings from pathology reports using 15 differ...
In a cohort of 351 female breast cancer patients who underwent neoadjuvant chemotherapy (NAC) and subsequent surgery between 2010 and 2017 in Calgary, the optimized method displayed a sensitivity of 9...
The study successfully demonstrates the efficacy of LLMs in interpreting and processing digital pathology data, particularly for determining pCR in breast cancer patients post-NAC. The superior perfor...
Hypoxia mediates treatment resistance in solid tumors. We evaluated if oxygen-enhanced (OE)-MRI-derived hypoxic volume (HVMRI) is repeatable and can detect radiotherapy-induced hypoxia modification in...
27 patients were recruited prospectively between March 2021 and January 2024. HVMRI was measured in primary and nodal tumors prior to standard-of-care (chemo)radiotherapy then at weeks 2 and 4 (W2, W4...
OE-MRI identified hypoxia in all lesions. HVMRI wCV was 24.6% and RC LOA were -45.7% to 84.1%. Cohort median pre-treatment HVMRI of 11.3 cm3 reduced to 6.9 cm3 at W2 and 5.9 cm3 at W4 (both p < 0.001)...
Radiation-induced hypoxia modification can occur as early as W2, but onset varies between patients and was not necessarily associated with overall size change. Half of all patients had discordant chan...
This study aims to assess the diagnostic capabilities of Diffusion Kurtosis Imaging (DKI) and Intravoxel Incoherent Motion (IVIM) in prostate cancer (PCa) detection and characterization....
A comprehensive search was conducted across PubMed, Scopus, Web of Science, and the Cochrane Library for articles published up to September 10, 2023, that evaluated the diagnostic efficacy of MD, MK, ...
In total, 27 studies were included. The analysis revealed distinct diagnostic efficacies for DKI and IVIM. In the overall model, sensitivity and specificity were 0.807 and 0.797, respectively, with pr...
In summary, the study underscores DKI's enhanced diagnostic accuracy over IVIM in detecting PCa, with MK standing out for its precision. Conversely, Dp and f lag in diagnostic performance. Despite the...
Oral squamous cell carcinomas (OSCC) seen in the oral cavity are a category of diseases for which dentists may diagnose and even cure. This study evaluated the performance of diagnostic computer softw...
Oral cancer lesions were labeled with CranioCatch labeling program (CranioCatch, Eskişehir, Turkey) and polygonal type labeling method on a total of 65 anonymous retrospective intraoral patient images...
When the success rate in estimating the images reserved for the test not used in education was evaluated, the F1, sensitivity and precision results of the artificial intelligence model obtained using ...
Our study reveals that OCSCC lesions carry discriminative visual appearances, which can be identified by deep learning algorithm. Artificial intelligence shows promise in the prediagnosis of oral canc...
Artificial intelligence (AI) systems can potentially aid the diagnostic pathway of prostate cancer by alleviating the increasing workload, preventing overdiagnosis, and reducing the dependence on expe...
In this international, paired, non-inferiority, confirmatory study, we trained and externally validated an AI system (developed within an international consortium) for detecting Gleason grade group 2 ...
Of the 10 207 examinations included from Jan 1, 2012, through Dec 31, 2021, 2440 cases had histologically confirmed Gleason grade group 2 or greater prostate cancer. In the subset of 400 testing cases...
An AI system was superior to radiologists using PI-RADS (2.1), on average, at detecting clinically significant prostate cancer and comparable to the standard of care. Such a system shows the potential...
Health~Holland and EU Horizon 2020....